pillbase.ru

Lumykras

Active substance: sotorasib

sotorasib

Centralised EU authorisationActive

Marketing holder: Amgen Europe B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • LUMAKRAS
    TABLET, COATED · SOTORASIB 320 mg/1
    55513-504
    Amgen Inc
  • LUMAKRAS
    TABLET, COATED · SOTORASIB 120 mg/1
    55513-488
    Amgen Inc
  • LUMAKRAS
    TABLET, COATED · SOTORASIB 240 mg/1
    55513-512
    Amgen Inc
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-7a30-727a-bb7f-a6b0ab8c6969,01a1209b-3c9e-79cc-acdb-c948c102bb08,01a1209d-8ce1-7cd4-a4aa-e642798368ae;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005522
Registration status
Active
ATC code
L01XX73
Sources
  • product · EMA · EMEA/H/C/005522 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005522 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005522 · Verified 2026-10-09